1. Home
  2. AGIO vs SHO Comparison

AGIO vs SHO Comparison

Compare AGIO & SHO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Agios Pharmaceuticals Inc.

AGIO

Agios Pharmaceuticals Inc.

HOLD

Current Price

$26.87

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

SHO

Sunstone Hotel Investors Inc. Sunstone Hotel Investors Inc.

HOLD

Current Price

$9.23

Market Cap

1.8B

ML Signal

HOLD

Company Overview

Basic Information
Metric
AGIO
SHO
Founded
2007
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Hotels/Resorts
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.8B
IPO Year
2013
1995

Fundamental Metrics

Financial Performance
Metric
AGIO
SHO
Price
$26.87
$9.23
Analyst Decision
Buy
Hold
Analyst Count
9
8
Target Price
$32.13
$9.31
AVG Volume (30 Days)
2.7M
1.9M
Earning Date
10-30-2025
11-07-2025
Dividend Yield
N/A
3.90%
EPS Growth
N/A
N/A
EPS
N/A
0.01
Revenue
$44,791,000.00
$937,930,000.00
Revenue This Year
$28.75
$5.75
Revenue Next Year
$139.45
$5.65
P/E Ratio
N/A
$962.16
Revenue Growth
36.26
3.04
52 Week Low
$22.24
$7.45
52 Week High
$46.00
$12.41

Technical Indicators

Market Signals
Indicator
AGIO
SHO
Relative Strength Index (RSI) 35.66 51.63
Support Level $26.80 $8.84
Resistance Level $28.61 $9.48
Average True Range (ATR) 1.15 0.19
MACD 0.28 0.01
Stochastic Oscillator 16.59 58.59

Price Performance

Historical Comparison
AGIO
SHO

About AGIO Agios Pharmaceuticals Inc.

Agios Pharmaceuticals Inc is a biopharmaceutical company focused on the field of cellular metabolism to create differentiated medicines for rare diseases, with a focus on classical hematology. The company's primary focus is to develop potentially transformative small-molecule medicines. Its product candidate, Pyrukynd (mitapivat), is an activator of both wild-type and mutant pyruvate kinase enzymes, developed for the treatment of hemolytic anemias. The other drug candidates in its pipeline include Tebapivat (PK activator), being developed as a potential treatment for MDS-associated anemia and sickle cell disease, AG-181 (PAH stabilizer), AG-236, and others.

About SHO Sunstone Hotel Investors Inc. Sunstone Hotel Investors Inc.

Sunstone Hotel Investors Inc is a real estate investment trust that acquires, owns, manages, and renovates the full-service hotel and select-service hotel properties across various states in the United States. Its firm's portfolio consists upper upscale and luxury hotels located in convention, resort destination and urban markets. Its majority of the hotels operate under a brand owned by Marriott, Hilton, Hyatt, Four Seasons or Montage. It operates geographically in Califiornia which generates the majority of its revenue; Florida; and Hawaii. The company's sole source of income is hotel revenue from its hotel ownership segment.

Share on Social Networks: